Attila Virág

Title: Attila Virág: Innovator in Pharmaceutical Development

Introduction

Attila Virág is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for drug formulation. With a total of 3 patents to his name, his work focuses on addressing critical neurodegenerative and neurodevelopmental diseases.

Latest Patents

Virág's latest patents include innovative formulations of Blarcamesine co-crystals. These formulations are designed for the manufacture of pharmaceutical dosage forms, specifically targeting conditions such as Alzheimer's disease, Parkinson's disease dementia, and Rett syndrome. The patents detail the processes for preparing these co-crystals, including the racemic-(±)-blarcamesine hydrochloride and its enantiomers, (S)-(−)-blarcamesine hydrochloride and (R)-(+)-blarcamesine hydrochloride.

Career Highlights

Attila Virág is currently employed at Egis Gyógyszergyár Zrt., a leading pharmaceutical company in Hungary. His work at Egis has allowed him to focus on innovative drug development, contributing to the advancement of treatments for complex neurological conditions.

Collaborations

Throughout his career, Virág has collaborated with notable colleagues, including Zsuzsanna Szokol and Tamás Nagy. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Attila Virág's contributions to pharmaceutical innovation, particularly in the area of neurodegenerative diseases, highlight his role as a key inventor in the field. His work continues to pave the way for new treatment options that can significantly impact patient care.